BIOCHEMICAL EFFECTS OF D-TETRANDRINE AND THALICARPINE

被引:15
作者
CREASEY, WA
机构
[1] YALE UNIV,SCH MED,DEPT INTERN MED,NEW HAVEN,CT 06510
[2] YALE UNIV,SCH MED,DEPT PHARMACOL,NEW HAVEN,CT 06510
关键词
D O I
10.1016/0006-2952(76)90194-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1887 / 1891
页数:5
相关论文
共 18 条
[1]   BINDING OF A NEW ANTITUMOR AGENT, THALICARPINE, TO DNA [J].
ALLEN, LM ;
CREAVEN, PJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (03) :474-475
[2]  
ALLEN LM, 1973, CANCER RES, V33, P3112
[3]  
BEREZHlNSKAYA V. V., 1965, FARMAKOL TOKSIKOL, V28, P77
[5]   BIOCHEMICAL EFFECTS OF VINCA ALKALOIDS .4. STUDIES WITH VINLEUROSINE [J].
CREASEY, WA .
BIOCHEMICAL PHARMACOLOGY, 1969, 18 (01) :227-&
[6]   BIOCHEMICAL EFFECTS OF VINCA ALKALOIDS .3. SYNTHESIS OF RIBONUCLEIC ACID AND INCORPORATION OF AMINO ACIDS IN EHRLICH ASCITES CELLS IN VITRO [J].
CREASEY, WA ;
MARKIW, ME .
BIOCHIMICA ET BIOPHYSICA ACTA, 1965, 103 (04) :635-&
[7]  
DECONTI RC, 1975, P AM ASSOC CANC RES, V16, P96
[8]   PHARMACOLOGICAL ACTIVITY OF THALICARPINE [J].
HAHN, RA ;
NELSON, JW ;
TYE, A ;
BEAL, JL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1966, 55 (05) :466-&
[9]  
Hartwell JL, 1969, ADV PHARMACOL CHEMOT, V7, P117, DOI 10.1016/S1054-3589(08)60561-X
[10]   STRUCTURAL REQUIREMENTS FOR TUMOR-INHIBITORY ACTIVITY AMONG BENZYLISOQUINOLINE ALKALOIDS AND RELATED SYNTHETIC COMPOUNDS [J].
KUPCHAN, SM ;
ALTLAND, HW .
JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (08) :913-917